SPS
Susquehanna Portfolio Strategies Portfolio holdings
AUM
$4.58B
This Quarter Return
+11.22%
1 Year Return
+20.83%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.46B
AUM Growth
+$1.46B
(-40%)
Cap. Flow
-$1.15B
Cap. Flow
% of AUM
-78.47%
Top 10 Holdings %
Top 10 Hldgs %
24.99%
Holding
506
New
7
Increased
3
Reduced
159
Closed
158
Top Buys
| 1 |
Strategy Inc Common Stock Class A
MSTR
|
$3.27M |
| 2 |
CorVel
CRVL
|
$230K |
| 3 |
Granite Construction
GVA
|
$230K |
| 4 |
AptarGroup
ATR
|
$227K |
| 5 |
LeMaitre Vascular
LMAT
|
$217K |
Top Sells
| 1 |
Kenvue
KVUE
|
$116M |
| 2 |
Emcor
EME
|
$69.2M |
| 3 |
Chubb
CB
|
$40.4M |
| 4 |
Medpace
MEDP
|
$38.5M |
| 5 |
Agilent Technologies
A
|
$32.7M |
Sector Composition
| 1 | Financials | 27.06% |
| 2 | Healthcare | 18.3% |
| 3 | Technology | 12.13% |
| 4 | Industrials | 9.88% |
| 5 | Real Estate | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMPS
326
Compass Pathways
CMPS
$434M
| $132K | 0.01% |
21,005
| – | – |
|
327
SandRidge Energy
SD
$445M
| $123K | 0.01% |
10,050
-15,444
| -61% | -$189K |
|
328
Applied Therapeutics
APLT
$74.9M
| $120K | 0.01% |
14,099
| – | – |
|
329
Beyond Meat
BYND
$182M
| $119K | 0.01% |
17,619
-10,591
| -38% | -$71.8K |
|
330
Virgin Galactic
SPCE
$178M
| $118K | 0.01% |
19,378
| – | – |
|
331
Skillz
SKLZ
$134M
| $103K | 0.01% |
18,341
-7,383
| -29% | -$41.5K |
|
|
EXAI
332
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $81.9K | 0.01% |
16,777
| – | – |
|
|
BHR
333
Braemar Hotels & Resorts
BHR
$188M
| $79.7K | 0.01% |
25,787
-59,100
| -70% | -$183K |
|
334
Bumble
BMBL
$634M
| $77.6K | 0.01% |
12,156
-183,006
| -94% | -$1.17M |
|
|
BLDP
335
Ballard Power Systems
BLDP
$559M
| $72K | ﹤0.01% |
40,000
-13,900
| -26% | -$25K |
|
336
GoPro
GPRO
$236M
| $65K | ﹤0.01% |
47,828
-180,709
| -79% | -$246K |
|
337
fuboTV
FUBO
$1.29B
| $62.8K | ﹤0.01% |
44,241
-112,137
| -72% | -$159K |
|
338
Unisys
UIS
$272M
| $58.8K | ﹤0.01% |
10,355
-8,748
| -46% | -$49.7K |
|
339
Acumen Pharmaceuticals
ABOS
$82.4M
| $54.3K | ﹤0.01% |
21,903
| – | – |
|
340
Stitch Fix
SFIX
$679M
| $48.5K | ﹤0.01% |
17,206
-60,597
| -78% | -$171K |
|
341
ALX Oncology
ALXO
$55.2M
| $47.6K | ﹤0.01% |
26,161
-47,307
| -64% | -$86.1K |
|
342
Peloton Interactive
PTON
$3.01B
| $46.8K | ﹤0.01% |
10,000
-350,943
| -97% | -$1.64M |
|
343
Advantage Solutions
ADV
$564M
| $39.2K | ﹤0.01% |
11,436
| – | – |
|
344
ImmunityBio
IBRX
$2.25B
| $38.7K | ﹤0.01% |
10,392
| – | – |
|
345
Kodiak Sciences
KOD
$455M
| $27.3K | ﹤0.01% |
10,473
-77,543
| -88% | -$202K |
|
|
TE
346
T1 Energy Inc.
TE
$295M
| $24.2K | ﹤0.01% |
24,900
| – | – |
|
347
Alto Ingredients
ALTO
$87.5M
| $23.5K | ﹤0.01% |
14,599
| – | – |
|
348
Luminar Technologies
LAZR
$112M
| $17.1K | ﹤0.01% |
18,997
| – | – |
|
349
Stoke Therapeutics
STOK
$1.07B
| – | – |
-43,424
| Closed | -$587K |
|
350
Constellation Brands
STZ
$26.7B
| – | – |
-6,086
| Closed | -$1.57M |
|